Literature DB >> 32741485

Aggressive Pituitary Adenomas and Carcinomas.

Mirela Diana Ilie1, Emmanuel Jouanneau2, Gérald Raverot3.   

Abstract

A subset of pituitary tumors present an aggressive behavior that remains difficult to predict, and in rare cases they metastasize. The current European Society for Endocrinology (ESE) guidelines for the management of aggressive pituitary tumors and carcinomas provide valuable guidance, but several issues remain unaddressed because of the scarcity of data in the literature. This article presents key clinical aspects regarding aggressive pituitary tumors and carcinomas, and also discusses some of the unanswered questions of the ESE guidelines, focusing on both diagnosis and treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggressive pituitary tumor; Definition; Diagnosis; Pituitary carcinoma; Stupp protocol; Temozolomide; Treatment; Tumor growth

Mesh:

Year:  2020        PMID: 32741485     DOI: 10.1016/j.ecl.2020.05.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  13 in total

Review 1.  Aggressive prolactinoma (Review).

Authors:  Ana Valea; Florica Sandru; Aida Petca; Mihai Cristian Dumitrascu; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

Review 2.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

3.  Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

Review 4.  Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  Diagnostics (Basel)       Date:  2022-04-13

5.  Plurihormonal PIT-1-Positive Pituitary Adenomas: A Systematic Review and Single-Center Series.

Authors:  John P Andrews; Rushikesh S Joshi; Matheus P Pereira; Taemin Oh; Alexander F Haddad; Kaitlyn M Pereira; Robert C Osorio; Kevin C Donohue; Zain Peeran; Sweta Sudhir; Saket Jain; Angad Beniwal; Ashley S Chopra; Narpal S Sandhu; Tarik Tihan; Lewis Blevins; Manish K Aghi
Journal:  World Neurosurg       Date:  2021-04-20       Impact factor: 2.210

Review 6.  The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.

Authors:  Congxin Dai; Siyu Liang; Bowen Sun; Jun Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-11       Impact factor: 5.555

7.  Is Seed and Soil Theory Suitable for Metastatic Spread of Pituitary Carcinomas?

Authors:  Congxin Dai; Bowen Sun; Jun Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-05       Impact factor: 5.555

Review 8.  How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.

Authors:  Congxin Dai; Jun Kang; Xiaohai Liu; Yong Yao; Haijun Wang; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-17       Impact factor: 5.555

9.  The Clinical and Pathological Characteristics of Refractory Pituitary Adenomas: A Single Center Experience.

Authors:  Xiaohai Liu; Congxin Dai; Xinjie Bao; Kan Deng; Yong Yao; Ming Feng; Mingchu Li; Ge Chen; Renzhi Wang
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

Review 10.  Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section.

Authors:  Sam Ng; Mahmoud Messerer; Julien Engelhardt; Michaël Bruneau; Jan Frederick Cornelius; Luigi Maria Cavallo; Giulia Cossu; Sebastien Froelich; Torstein R Meling; Dimitrios Paraskevopoulos; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Moncef Berhouma; Roy T Daniel; Edward R Laws; Engelbert Knosp; Michael Buchfelder; Henri Dufour; Stéphane Gaillard; Timothée Jacquesson; Emmanuel Jouanneau
Journal:  Acta Neurochir (Wien)       Date:  2021-08-08       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.